Spero Therapeutics (2HA.STU) Q1 2026 Earnings

26MarConfirmed
Q1 2026
-0.17
0.04
0.25
0.46

Details

Expected EPS
-0.17328
Actual EPS
0.459192
Surprise EPS
0.63
Surprise Percent
+365%

Description

Spero Therapeutics (2HA.STU) has reported earnings of 0.459192 per share for Q1 2026.

0 Comments

Share your thoughts